Drug Delivery Systems (trends) < Drug Design < Drug Development

Facettes : AffPays.f Mesh.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 126.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000081 (2003)	Kanchan Anand [Allemagne] ; John Ziebuhr ; Parvesh Wadhwani ; Jeroen R. Mesters ; Rolf Hilgenfeld	Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.
000124 (2003)	Kathryn V. Holmes [États-Unis] ; Luis Enjuanes	Virology. The SARS coronavirus: a postgenomic era.
000147 (2003)	Bin Xiong [République populaire de Chine] ; Chun-Shan Gui ; Xiao-Ying Xu ; Cheng Luo ; Jing Chen ; Hai-Bin Luo ; Li-Li Chen ; Guo-Wei Li ; Tao Sun ; Chang-Ying Yu ; Li-Duo Yue ; Wen-Hu Duan ; Jing-Kang Shen ; Lei Qin ; Tie-Liu Shi ; Yi-Xue Li ; Kai-Xian Chen ; Xiao-Min Luo ; Xu Shen ; Jian-Hua Shen ; Hua-Liang Jiang	A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening.
000262 (2003)	Kuo-Chen Chou [États-Unis] ; Dong-Qing Wei ; Wei-Zhu Zhong	Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS.
000344 (2003)	Yossef Kliger [Israël] ; Erez Y. Levanon	Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy.
000483 (2003)	Xiang Xu [République populaire de Chine] ; Yunqing Liu ; Susan Weiss ; Eddy Arnold ; Stefan G. Sarafianos ; Jianping Ding	Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design.
000699 (2004)	Mayuko Takeda-Shitaka [Japon] ; Daisuke Takaya ; Chieko Chiba ; Hirokazu Tanaka ; Hideaki Umeyama	Protein structure prediction in structure based drug design.
000748 (2004)	Xue Wu Zhang [République populaire de Chine] ; Yee Leng Yap	Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design.
000798 (2004)	Mayuko Takeda-Shitaka [Japon] ; Hiroyuki Nojima ; Daisuke Takaya ; Kazuhiko Kanou ; Mitsuo Iwadate ; Hideaki Umeyama	Evaluation of homology modeling of the severe acute respiratory syndrome (SARS) coronavirus main protease for structure based drug design.
000841 (2004)	Guan-Hua Du [République populaire de Chine] ; Wei Wang ; Ke-Di Cheng ; Li-Li Cao ; Xiu-Ying Yang ; Ping Zhu	[Targets and studies on anti-SARS drugs].
000888 (2004)	Guang Wu [République populaire de Chine] ; Shaomin Yan	Potential targets for anti-SARS drugs in the structural proteins from SARS related coronavirus.
000903 (2004)	H-L Liu [Taïwan] ; J-C Lin ; Y. Ho ; W-C Hsieh ; C-W Chen ; Y-C Su	Molecular dynamics simulations of various coronavirus main proteinases.
000A65 (2004)	Rajendram V. Rajnarayanan [États-Unis] ; Sivanesan Dakshanamurthy ; Nagarajan Pattabiraman	"Teaching old drugs to kill new bugs": structure-based discovery of anti-SARS drugs.
000B00 (2004)	Dale L. Barnard [États-Unis]	American Society for Virology-23rd annual meeting. Vaccines and antiviral agents 10-14 July 2004, Montreal Canada.
000B01 (2004)	Steffen Nock [États-Unis]	Antibody World Summit 2004-SRI Conference 19-21 July 2004, Philadelphia, PA, USA.
000B29 (2004)	Matthew J. Huentelman [États-Unis] ; Jasenka Zubcevic ; Jose A. Hernández Prada ; Xiaodong Xiao ; Dimiter S. Dimitrov ; Mohan K. Raizada ; David A. Ostrov	Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor.
000B51 (2004)	Qi-Shi Du [République populaire de Chine] ; Shu-Qing Wang ; Yu Zhu ; Dong-Qing Wei ; Hong Guo ; Suzanne Sirois ; Kuo-Chen Chou	Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide.
000C93 (2003)	Ken Yan Ching Chow ; Chung Chau Hon ; Raymond Kin Hi Hui ; Raymond Tsz Yeung Wong ; Chi Wai Yip ; Fanya Zeng ; Frederick Chi Ching Leung	Molecular Advances in Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)
000D48 (2004)	Jesus F. Bermejo [Espagne] ; M Angeles Mu Oz-Fernandez	Severe acute respiratory syndrome, a pathological immune response to the new coronavirus--implications for understanding of pathogenesis, therapy, design of vaccines, and epidemiology.
000D65 (2005)	Bing Liu [République populaire de Chine] ; Jiaju Zhou	SARS-CoV protease inhibitors design using virtual screening method from natural products libraries.
000F34 (2005)	Jindrich Cinatl [Allemagne] ; Martin Michaelis ; Gerold Hoever ; Wolfgang Preiser ; Hans Wilhelm Doerr	Development of antiviral therapy for severe acute respiratory syndrome.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Drug Design" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Drug Design" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Drug Design
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021